111 related articles for article (PubMed ID: 22507687)
1. Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal.
Frieling H; Leitmeier V; Haschemi-Nassab M; Kornhuber J; Rhein M; Bleich S; Hillemacher T
Eur Neuropsychopharmacol; 2012 Nov; 22(11):836-40. PubMed ID: 22507687
[TBL] [Abstract][Full Text] [Related]
2. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Selley ML
Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
van Guldener C; Nanayakkara PW; Stehouwer CD
Clin Chem Lab Med; 2007; 45(12):1683-7. PubMed ID: 17937610
[TBL] [Abstract][Full Text] [Related]
4. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects.
Holven KB; Haugstad TS; Holm T; Aukrust P; Ose L; Nenseter MS
Br J Nutr; 2003 Mar; 89(3):359-63. PubMed ID: 12628031
[TBL] [Abstract][Full Text] [Related]
5. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine, homocysteine and renal function--is there a relation?
Siroká R; Trefil L; Rajdl D; Racek J; Rusnáková H; Cibulka R; Eiselt J; Filipovský J
Clin Chem Lab Med; 2005; 43(10):1147-50. PubMed ID: 16197312
[TBL] [Abstract][Full Text] [Related]
8. The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia.
Demir B; Demir S; Pasa S; Guven S; Atamer Y; Atamer A; Kocyigit Y
J Obstet Gynaecol; 2012 Aug; 32(6):525-8. PubMed ID: 22779953
[TBL] [Abstract][Full Text] [Related]
9. An assessment of the potential value of elevated homocysteine in predicting alcohol-withdrawal seizures.
Bleich S; Bayerlein K; Hillemacher T; Degner D; Kornhuber J; Frieling H
Epilepsia; 2006 May; 47(5):934-8. PubMed ID: 16686660
[TBL] [Abstract][Full Text] [Related]
10. Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: results from the German Investigation on Neurobiology in Alcoholism (GINA).
Heese P; Linnebank M; Semmler A; Muschler MA; Heberlein A; Frieling H; Stoffel-Wagner B; Kornhuber J; Banger M; Bleich S; Hillemacher T
Alcohol Alcohol; 2012; 47(5):497-500. PubMed ID: 22645037
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
Korandji C; Zeller M; Guilland JC; Vergely C; Sicard P; Duvillard L; Gambert P; Moreau D; Cottin Y; Rochette L
Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
[TBL] [Abstract][Full Text] [Related]
13. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
Wilcken DE; Sim AS; Wang J; Wang XL
Mol Genet Metab; 2007 Aug; 91(4):309-17; discussion 308. PubMed ID: 17560156
[TBL] [Abstract][Full Text] [Related]
15. Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism.
Wilhelm J; Bayerlein K; Hillemacher T; Reulbach U; Frieling H; Kromolan B; Degner D; Kornhuber J; Bleich S
J Neural Transm (Vienna); 2006 Mar; 113(3):357-63. PubMed ID: 15997414
[TBL] [Abstract][Full Text] [Related]
16. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
17. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis.
Koyama K; Ito A; Yamamoto J; Nishio T; Kajikuri J; Dohi Y; Ohte N; Sano A; Nakamura H; Kumagai H; Itoh T
Am J Kidney Dis; 2010 Jun; 55(6):1069-78. PubMed ID: 20430500
[TBL] [Abstract][Full Text] [Related]
20. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
